Laxmi Organic Industries Ltd
Laxmi Organic Industries Limited was established in 1989 and is in the business of specialty chemicals. The Company primarily manufactures Ethyl Acetate, Acetic Acid and Diketene Derivative Products (DDP). DDP is a specialty chemical group, the technology and business of which has been acquired by the company from Clariant Chemicals India Limited.
The company’s business operations are carried in over 30 countries including 11 offices located in India
- Market Cap ₹ 5,137 Cr.
- Current Price ₹ 185
- High / Low ₹ 326 / 160
- Stock P/E 45.3
- Book Value ₹ 68.8
- Dividend Yield 0.34 %
- ROCE 8.82 %
- ROE 6.13 %
- Face Value ₹ 2.00
Pros
Cons
- Stock is trading at 2.85 times its book value
- Company has a low return on equity of 7.40% over last 3 years.
- Dividend payout has been low at 12.2% of profits over last 3 years
- Promoter holding has decreased over last 3 years: -3.54%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Chemicals Industry: Chemicals
Part of BSE 500 BSE SmallCap BSE Allcap BSE Commodities BSE 250 SmallCap Index
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|
1,074 | 1,047 | 1,076 | 1,376 | 1,569 | 1,534 | 1,768 | 3,084 | 2,791 | 2,863 | 2,985 | |
988 | 966 | 957 | 1,222 | 1,414 | 1,418 | 1,548 | 2,713 | 2,548 | 2,605 | 2,706 | |
Operating Profit | 86 | 80 | 119 | 154 | 155 | 117 | 220 | 371 | 243 | 259 | 280 |
OPM % | 8% | 8% | 11% | 11% | 10% | 8% | 12% | 12% | 9% | 9% | 9% |
1 | 2 | 2 | 3 | 6 | 30 | 4 | 15 | 18 | 28 | 25 | |
Interest | 26 | 19 | 11 | 12 | 19 | 17 | 19 | 19 | 15 | 9 | 20 |
Depreciation | 30 | 29 | 28 | 31 | 44 | 49 | 47 | 48 | 72 | 107 | 124 |
Profit before tax | 31 | 34 | 82 | 113 | 98 | 81 | 158 | 319 | 173 | 171 | 161 |
Tax % | 31% | 22% | 13% | 33% | 26% | 13% | 20% | 19% | 28% | 29% | 29% |
21 | 27 | 72 | 76 | 72 | 70 | 127 | 257 | 125 | 121 | 114 | |
EPS in Rs | 21.12 | 26.56 | 71.50 | 75.63 | 14.46 | 15.57 | 4.82 | 9.76 | 4.70 | 4.37 | 4.10 |
Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 11% | 10% | 7% | 11% | 14% | 12% |
Compounded Sales Growth | |
---|---|
10 Years: | 11% |
5 Years: | 14% |
3 Years: | -1% |
TTM: | 4% |
Compounded Profit Growth | |
---|---|
10 Years: | 18% |
5 Years: | 18% |
3 Years: | -24% |
TTM: | -4% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | -18% |
1 Year: | -24% |
Return on Equity | |
---|---|
10 Years: | 12% |
5 Years: | 11% |
3 Years: | 7% |
Last Year: | 6% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 10 | 10 | 10 | 10 | 50 | 45 | 53 | 53 | 53 | 55 | 55 |
Reserves | 199 | 225 | 295 | 369 | 400 | 382 | 982 | 1,237 | 1,359 | 1,742 | 1,851 |
249 | 221 | 104 | 215 | 175 | 159 | 149 | 139 | 406 | 143 | 258 | |
152 | 176 | 240 | 300 | 389 | 484 | 654 | 820 | 595 | 887 | 880 | |
Total Liabilities | 610 | 632 | 649 | 895 | 1,014 | 1,069 | 1,838 | 2,249 | 2,412 | 2,827 | 3,045 |
226 | 215 | 202 | 293 | 346 | 338 | 325 | 379 | 715 | 879 | 1,166 | |
CWIP | 25 | 40 | 61 | 30 | 31 | 67 | 148 | 374 | 447 | 444 | 398 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 5 | 23 | 126 | 148 |
358 | 377 | 386 | 571 | 637 | 664 | 1,361 | 1,492 | 1,228 | 1,378 | 1,332 | |
Total Assets | 610 | 632 | 649 | 895 | 1,014 | 1,069 | 1,838 | 2,249 | 2,412 | 2,827 | 3,045 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|
80 | 150 | -7 | 188 | 196 | 106 | 65 | 199 | 562 | |||
-21 | -37 | -85 | -123 | -56 | -641 | 76 | -384 | -490 | |||
-57 | -107 | 85 | -63 | -123 | 527 | -124 | 232 | -42 | |||
Net Cash Flow | 1 | 6 | -7 | 2 | 16 | -7 | 17 | 47 | 30 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 64 | 67 | 79 | 86 | 76 | 86 | 90 | 79 | 75 | 74 | 66 |
Inventory Days | 37 | 57 | 37 | 55 | 57 | 51 | 63 | 64 | 58 | 54 | 71 |
Days Payable | 52 | 67 | 85 | 81 | 105 | 138 | 148 | 122 | 92 | 145 | 131 |
Cash Conversion Cycle | 49 | 56 | 30 | 60 | 28 | -1 | 5 | 21 | 41 | -16 | 6 |
Working Capital Days | 65 | 66 | 36 | 65 | 43 | 25 | 27 | 58 | 66 | 24 | 55 |
ROCE % | 12% | 22% | 25% | 19% | 12% | 20% | 26% | 12% | 9% | 9% |
Documents
Announcements
-
Intimation Of Statement Of Deviation And Variation Under Regulation 32(1) Of SEBI (Listing Obligations
And Disclosure Requirements) Regulations, 2015
3h - No deviation in IPO proceeds utilization for quarter ended March 31, 2025, per SEBI norms.
-
Intimation Of Statement Of Deviation And Variation Under Regulation 32(1) Of SEBI (Listing Obligations
And Disclosure Requirements) Regulations, 2015
3h - No deviation in QIP fund use; Rs 2591.21 Mn allocated as per original objects.
-
Announcement under Regulation 30 (LODR)-Monitoring Agency Report
3h - No deviation in IPO proceeds utilization; monitoring report for quarter ended March 31, 2025.
-
Intimation Of Record Date For The Purpose Of Final Dividend
5h - Record date set as July 18, 2025 for final dividend eligibility FY 2024-25.
-
Grant Of Employee Stock Options As Per Laxmi - Employee Stock Option Plan 2024 ('ESOP-2024')
4h - Grant of 676,543 stock options at Rs.126 each under ESOP-2024 approved on May 20, 2025.
Annual reports
Concalls
-
May 2025TranscriptNotesPPT
-
Jan 2025Transcript PPT
-
Nov 2024Transcript PPT
-
Aug 2024Transcript PPT
-
Jul 2024TranscriptNotesPPT
-
May 2024Transcript PPT REC
-
Feb 2024Transcript PPT
-
Oct 2023Transcript PPT REC
-
Oct 2023TranscriptNotesPPT
-
Aug 2023Transcript PPT
-
Jul 2023TranscriptNotesPPT
-
May 2023TranscriptPPT
-
May 2023Transcript PPT
-
Jan 2023Transcript PPT
-
Nov 2022Transcript PPT
-
Nov 2022TranscriptNotesPPT
-
Aug 2022Transcript PPT
-
Jul 2022TranscriptNotesPPT
-
May 2022TranscriptNotesPPT
-
Feb 2022TranscriptNotesPPT
-
Nov 2021TranscriptNotesPPT
-
Aug 2021TranscriptNotesPPT
-
May 2021Transcript PPT
Product Portfolio[1]
a) Essentials Segment
The Segment includes products like Ethyl Acetate, Acetic Anhydride, Acetaldehyde, various solvents, ethanol, and n-Butyl/Ethyl Acetate. These cater primarily to the pharmaceutical, packaging, and industrial sectors.